Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Done EAZY: An Automated Procedure for <sup>89</sup>Zr-Radiolabeling and Size-Exclusion Chromatography Purification of Nanoliposomal Anticancer Therapeutics.

Molecular pharmaceutics·2026

Same author

Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment.

Cancer research communications·2026

Same author

HDAC7 controls anti-viral and anti-tumor immunity by CD8<sup>+</sup> T cells.

Frontiers in immunology·2026

Same author

[Imaging of visceral, retroperitoneal, and pelvic soft-tissue sarcomas : Review].

Radiologie (Heidelberg, Germany)·2026

Same author

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Nature communications·2026

Same author

MyCODE: a prospective evaluation of lay-language molecular tumor board protocols in precision oncology.

The oncologist·2026

Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026

Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026

Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026

Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026

Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026

Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 3, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Preclinical models for translational sarcoma research.

Rainer Hamacher¹, Sebastian Bauer

¹aDepartment of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen bGerman Cancer Consortium (DKTK), Heidelberg, Germany.

Current Opinion in Oncology

|April 27, 2017

Summary

This summary is machine-generated.

Advancements in sarcoma research rely on sophisticated preclinical models. These models, including cell lines and patient-derived xenografts, are crucial for identifying new therapeutic targets and improving patient outcomes in sarcoma treatment.

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

The In ovo CAM-assay as a Xenograft Model for Sarcoma

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Related Experiment Videos

Last Updated: Mar 3, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

The In ovo CAM-assay as a Xenograft Model for Sarcoma

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Area of Science:

Oncology
Translational Research
Genomics

Background:

Sarcoma encompasses over 75 subtypes of mesenchymal tumors.
Current chemotherapies offer limited improvement for metastatic sarcoma patients.
Genomic heterogeneity poses challenges for effective sarcoma treatment.

Purpose of the Study:

To review current preclinical model systems in sarcoma research.
To discuss the translational relevance of these models.
To highlight advancements in developing novel sarcoma models.

Main Methods:

Utilizing cell culture for identifying therapeutic approaches and resistance mechanisms.
Employing genome-wide and proteome-wide screening techniques.
Developing patient-derived xenografts and genetically engineered models.

Main Results:

Preclinical models are essential for identifying molecular targets and prioritizing drug combinations.
Patient-derived xenografts improve preclinical studies with primary human samples.
Genome editing technologies facilitate the creation of novel cell lines and mouse models.

Conclusions:

Current sarcoma research employs diverse model systems, including cell lines and xenografts.
Advancements in genome editing are leading to improved genetically engineered models.
These models are vital for advancing sarcoma therapeutics and understanding resistance mechanisms.